Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic products. It also provides molecular diagnostic reagents, and scientific research and testing services for blood diseases, solid tumors, and infectious diseases. The company was founded in 2012 and is based in Shanghai, China.
Stock data | 2024 | Change |
---|---|---|
Price | $1.90 | N/A |
Market Cap | $106.26M | N/A |
Shares Outstanding | 55.86M | N/A |
Employees | 503.00 | N/A |